Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGAP42 pseudogene 1 (ARHGAP42P1) is a processed pseudogene related to the ARHGAP42 gene. There is no evidence that ARHGAP42P1 encodes a functional protein or participates as a therapeutic target. The actual protein-coding gene, ARHGAP42 (Rho GTPase-activating protein 42), is involved in regulation of blood pressure and vascular tone, but ARHGAP42P1, as a pseudogene, is not a receptor, enzyme, transporter, or established drug target. Pseudogenes can sometimes have regulatory RNA functions, but there is no current literature supporting clinical or pharmacological targeting of ARHGAP42P1. Therefore, this entry is not a valid therapeutic target and should be considered incorrect if selected as such.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGAP42 pseudogene 1 (ARHGAP42P1).